Healthcare services group Uniphar has announced deals to buy three companies today - Irish-headquartered pharmacy services group Navi Group and two UK-based firms brand E4H and Devonshire Healthcare Services.
Uniphar said the combined revenue of the acquisitions is €39m and the three deals will see 110 people joining the company.
Navi drives innovation within the Irish pharmacy sector through digital platforms and consistent supply of quality pharmaceutical products to its partners.
Uniphar said the technology and value proposition of Navi combined with its scalable high-tech distribution facilities and digital platforms will deliver an even stronger offering to its independent community pharmacy customer base.
The deal is subject to approval by the Irish Competition and Consumer Protection Commission and is anticipated to complete in the second quarter of 2022.
UK-based brand commercialisation and pharmaceutical marketing agency E4H offers a range of digital and communications solutions to the pharmaceutical industry.
These services include brand and strategy commercialisation, digital development, multi-channel delivery, engagement and data analysis.
Uniphar said it will be integrated into its Commercial & Clinical Pharma division and will enhance its value proposition of creating a truly differentiated omni-channel offering for pharmaceutical clients looking to commercialise their brands across Europe.
UK-based pharmaceutical distributor Devonshire Healthcare Services has provided access to unlicensed and difficult to source medicines across the Middle East and North Africa (MENA) region for 25 years to a broad variety of healthcare authorities, hospitals, overseas ministries of health and military agencies.
It will be integrated into Uniphar's Product Access division, expanding its global access into key hospitals in the MENA region.
Ger Rabbette, CEO of Uniphar, said the company was delighted to announce three acquisitions today, one across each of Uniphar's divisions.
The CEO said the deals accelerate Uniphar's our strategic objectives and demonstrate its continued focus on identifying and executing compelling M&A opportunities that meet or exceed its strict returns criteria.
"E4H’s digital capabilities and innovative services advance our commercial model to become a market leading omni-channel solution for our pharma partners," Ger Rabbette said.
"Devonshire's strong track record in servicing the MENA region unlocks new opportunities for our Product Access division and demonstrates our commitment to becoming a global leader in the provision of unlicensed and difficult to source medicines," he said.
"Navi’s highly sophisticated digital offering will be leveraged throughout the Supply Chain & Retail division and demonstrates our commitment to being a differentiated and market-leading service offering," he added.
